Anti-β2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease

Immunobiology

Volumn 212, Issue 3, 2007, Pages 193-199

  Salobir, Barbara ^a   Šabovič, Mišo ^a   Hojnik, Maja ^a   Čučnik, Saša ^a   Kveder, Tanja ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Antibodies against 2glycoprotein 1 (anti 2GPI); Metabolic syndrome; Thrombosis; Young women

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ADULT; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNE DISEASE; BLOOD CLOTTING; BODY MASS; BRAIN INFARCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOGENESIS; THROMBOSIS; VEIN THROMBOSIS;

EID: 33947726153     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.01.001     Document Type: Article

References (39)

1. Ambrožič A., Kveder T., Bozic B., and Rozman B. Comparison of different kits in the detection of autoantibodies to cardiolipin and β2-glycoprotein I: comment on the article by Audrain et al. Rheumatology 43 (2004) 1062-1063
2. Amengual O., Atsumi T., Khamashta M.A., Koike T., and Hughes G.R.V. Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome. Br. J. Rheumatol. 35 (1996) 1239-1243
3. Arnout J., and Vermylen J. Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. J. Thromb. Haemostas. 1 (2003) 931-942
4. Avčin T., Ambrožič A., Kuhar M., Kveder T., and Rozman B. Anticardiolipin and anti-β-glycoprotein 1 antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 40 (2001) 565-573
5. Bamford J., Sandercock P., Dennis M., Burn J., and Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337 (1991) 1521-1526
6. Brey R.L., Abbott R.D., Curb J.D., Sharp D.S., Ross G.W., Stallworth C.L., and Kittner S.J. Beta(2)-glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program. Stroke 32 (2001) 1701-1706
7. Buckell M. The effect of citrate on euglobulin methods of estimating fibrinolytic activity. J. Clin. Pathol. 11 (1958) 403-405
8. Čučnik S., Ambrožič A., Božič B., Skitek M., and Kveder T. Anti-β2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards. Clin. Chem. Lab. Med. 38 (2000) 777-783
9. Dahlback B., Carlsson M., and Svensson P.J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc. Natl. Acad. Sci. USA 90 (1993) 1004-1008
10. Fanopoulos D., Teodorescu M.R., Varga J., and Teodorescu M. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. J. Rheumatol. 25 (1998) 675-680
11. Farsi A., Domeneghetti M.P., Fedi S., Capanni M., Giusti B., Marcucci R., Giurlani L., Prisco D., Passaleva A., Gensini G.F., and Abbate R. High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart disease. Autoimmunity 30 (1999) 93-98
12. Forastiero R., Martinuzzo M., Adamczuk Y., and Carreras L.O. Occurrence of anti-prothrombin and anti-beta2-glycoprotein I antibodies in patients with history of thrombosis. J. Lab. Clin. Med. 134 (1999) 610-615
13. Galli M., and Barbui T. Antiphospholipid antibodies and thrombosis: strength of association. Hematol. J. 4 (2003) 180-186
14. Galli M., Dlott J., Norbis F., Ruggeri L., Cler L., Triplett D.A., and Barbui T. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests. Thromb. Haemostasis 84 (2000) 1012-1016
15. Gharavi E.E., Chaimovich H., Cucurull E., Celli C.M., Tang H., Wilson W.A., and Gharavi A.E. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus 8 (1999) 449-455
16. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 353 (1999) 1348-1353
17. Guerin J., Casey E., Feighery C., and Jackson J. Anti-beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients. Autoimmunity 31 (1999) 109-116
18. Hougie S. Determination of the thrombin time. Acta Haematol. 24 (1960) 130-138
19. Hughes G.R.V. Hughes' syndrome: the antiphospholipid syndrome. A historical view. Lupus 7 (1998) S1-S4
20. Hughes G. Speculation on APS in the coming millennium. Lupus 15 (2000) 269-271
21. Inanc M., Radway-Bright E.L., and Isenberg D.A. β2-glycoprotein I and anti-β2-glycoprotein I antibodies: where are we now?. Br. J. Rheumatol. 36 (1997) 1247-1257
22. Janeway, C.A., Travers, P., Walport, M., Shlomchik, M.J., 2001. The humoral immune response. In: Immunobiology. The Immune System in Health and Disease, 5th ed. Garland Churchill Livingstone, New York, pp. 341-380.
23. Juhan-Vague I., Alessi M.C., and Morange P.E. PAI-1, obesity and insulin resistance. In: Reaven G., and Laws A. (Eds). Contemporary Endocrinology: Insulin Resistance (1999), Human Press Inc., Totowa, NJ 317-332
24. Lakos G., Kiss E., Regeczy N., Tarjan P., Soltesz P., Zeher M., Bodolay E., Szakony S., Sipka S., and Szegedi G. Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype. Clin. Exp. Immunol. 117 (1999) 574-579
25. Laurell C.B. Electroimmunoassay. Scand. J. Clin. Lab. Invest. 29 (1972) 21-37
26. Lee S.S., Cho M.L., Joo Y.S., Kim W.U., Hong Y.S., Min J.K., Lee S.H., Park S.H., Cho C.S., and Kim H.Y. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus. J. Rheumatol. 28 (2001) 520-524
27. Myocardial Infarction Community Registers. Results of WHO International Collaborative Study (1976), World Health Organization Regional Office for Europe, Copenhagen, Denmark
28. Petri M. Epidemiology of antiphospholipid antibody syndrome. J. Autoimmun. 15 (2000) 145-151
29. Previtali S., Barbui T., and Galli M. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: a case control study. Thromb. Haemostasis 88 (2002) 729-732
30. Quick A.J., Stanley-Brown M., and Bancroft F.W. A study of the coagulation defect in hemophilia and jaundice. Am. J. Med. Sci. 190 (1935) 501-511
31. Reber G., Tincani A., Sanmarco M., de Moerloosep P., and Boffa M.C. European forum on antiphospholipid antibodies standardisation group. Variability of anti-beta2-glycoprotein I antibodies measurements by commercial assays. Thromb. Haemostasis 94 (2005) 665-672
32. Sanfilippo S.S., Khamashta M.A., Atsumi T., Amengual O., Bertolaccini M.L., D'Cruz D., Amft N., Swana G.T., and Hughes G.R. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. J. Rheumatol. 25 (1998) 2131-2134
33. Sherer Y., Tenenbaum A., Praprotnik S., Shemesh J., Blank M., Fisman E.Z., Motoro M., and Shoenfeld Y. Autoantibodies to cardiolipin and β2-glycoprotein I in coronary artery disease patients with and without hypertension. Cardiology 97 (2002) 2-5
34. Stegnar M., Božič B., Peternel P., Kveder T., Vene N., and Rozman B. Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis. Thromb. Res. 63 (1991) 433-443
35. Tsutsumi A. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythemathosus. Arthritis Rheum. 39 (1996) 1466-1474
36. Tsutsumi A., Matsuura E., Ichikawa K., and Koike T. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythemathosus: reply. Arthritis Rheum. 40 (1997) 1366-1367
37. Wood D., De Backer G., Faergeman O., Graham I., Mancia G., and Pyörälä K. Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention. Eur. Heart J. 19 (1998) 1434-1503
38. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. A multinational case-control study of cardiovascular disease and steroid hormone contraceptives: description and validation of methods. J. Clin. Epidemiol. 48 (1995) 1513-1547
39. Zanon E., Prandoni P., Vianello F., Saggiorato G., Carraro G., Bagatella P., and Girolami A. Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. Thromb. Res. 96 (1999) 269-274